Plausibly Exogenous [1779] - Pharmaceutical Innovation (12/16/2024)

LHS Variable
Number of subsequent entrant drugs in a pharmaceutical class

RHS Variable
Market exclusivity

Source of Exogenous Variation
Time gap between patent filing date and start of clinical development for the FIC drug

- Gilchrist (2016), “Patents as a spur to subsequent innovation? Evidence from pharmaceuticals”